In previous studies, it was also uncovered that the CD95/CD95L system is involved in the enhancement of stem cell phenotype (CD133 marker) of tumor cells, contributing to the development of an enhanced metastatic phenotype with high chemo-resistant properties [22]. The gene discussed is FAS; the disease is neoplasm.